In such patients, clinical and metabolic features of type 2 diabetes include a high rate of obesity, a strong family history of diabetes, a measurable pancreatic insulin reserve, low prevalence of autoimmune markers of ß-cell destruction, and the ability to discontinue insulin therapy during follow-up [49]. Here, INS is linked to diabetes mellitus.